Inspire Medical Systems (NYSE:INSP) announced today that Dr. Jerry C. Griffin intends to retire from its board of directors.
Griffin plans to retire at the conclusion of the company’s annual meeting of stockholders on May 2, 2024.
The longtime director joined the Inspire board in 2008 as one of the original board members. He joined before the company’s initial Series A financing round.
Most recently, Griffin served on the board’s Nominating and Corporate Governance Committee. He departs the board shortly after Inspire brought on another experienced member in Dr. Myriam J. Curet. Curet, whose appointment went into effect on Dec. 21, currently serves as EVP and chief medical officer at surgical robotics pioneer Intuitive Surgical.
“After sixteen years of service, we announce the retirement of Dr. Griffin from our board of directors. His contributions to our board and organization are innumerable and we are grateful for the dedication and direction he provided to our organization,” Tim Herbert, president and CEO of Inspire Medical Systems, said in a news release. “I want to personally thank Jerry for his years at Inspire, his invaluable expertise, guidance and partnership contributed to Inspire growing from a startup to a medical device company with over 60,000 patients treated, one thousand employees, and $600 million in annual revenue.”
Minneapolis-based Inspire Medical develops minimally invasive implantable products for treating obstructive sleep apnea. It offers an alternative to the traditional CPAP machines made by the likes of Philips and ResMed. Inspire Medical’s reputation has grown over the past several years as Philips dealt with a massive CPAP recall and people moved away from that method of treatment.